AzurRx BioPharma, Inc.
AzurRx BioPharma, Inc. (AZRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AZRX · as of Jun 9, 2026
Key Statistics
Explore AzurRx BioPharma, Inc. Data
azrx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
Competitors & Peers
azrx competitorsAZRX
BCEL
CYTO
GRTS
IDRA
LSTAStock Performance
Full HistoryAbout AzurRx BioPharma, Inc.
AzurRx BioPharma, Inc. a Brooklyn, New York-based company employing 12 full-time individuals, focuses on the discovery and advancement of non-systemic biological treatments for various gastrointestin…
what is azurrx biopharma, inc. · azrx stock overview · azurrx biopharma, inc. company profile · who is azurrx biopharma, inc. ceo · azrx NASDAQ · azurrx biopharma, inc. headquarters · azurrx biopharma, inc. business segments
About Stock Overview & Key Data
AzurRx BioPharma, Inc. (AZRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 11, 2016. As of the latest trading session, AZRX stock price is $3.45, with a market capitalization of $3.4M. The stock has returned +141.26% over the past 12 months and +0.00% year-to-date.
According to 4 Wall Street analysts, the consensus rating for AzurRx BioPharma, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, AzurRx BioPharma, Inc. reported revenue of $36251.00 and net income of -$6.6M. For detailed data — including AzurRx BioPharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, AzurRx BioPharma, Inc. (AZRX) stock price is $3.45. The stock is traded on NASDAQ under the ticker symbol AZRX. The 52-week range is $3.38 – $3.66.